Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × INDUSTRY × Lomustine × Clear all

Phase

Status

Completed 9 Terminated 4 Recruiting 3 Active not recruiting 3 Withdrawn 1 Unknown 1 Not yet recruiting 1

Sponsor Class

OTHER_GOV 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Injections 33 Carboplatin 26 Docetaxel 23 Paclitaxel 20 Capecitabine 20 pembrolizumab 19 Oxaliplatin 19 Cisplatin 18 Gemcitabine 14 Bevacizumab 14 Pemetrexed 13 Cyclophosphamide 11 Fluorouracil 10 tislelizumab 9 Drug Therapy 9 Leucovorin 8 Irinotecan 8 Doxorubicin 7 osimertinib 6 Trastuzumab 6 Nivolumab 6 palbociclib 5 lenvatinib 5 fludarabine 5 Topotecan 5 Prednisolone 5 Fulvestrant 5 Dexamethasone 5 130-nm albumin-bound paclitaxel 5 regorafenib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07120984 2025-08-13

IMAGLIO

Philogen S.p.A.

Phase 2 Not yet recruiting

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡